Stocks
Health Care
rapt
RAPT Therapeutics
NASDAQ: RAPT
+22.46 (+63.99%)
57.56
USD
At close at Jan 20, 21:43 UTC
Overview
Loading chart...
Key Stats
Market Cap
952.08M
Dividend Yield
0.00%
P/E Ratio
-9.01
EPS
-25.52
Revenue
-
Avg. Volume
8.14M
Recently from Cashu
No Cashu articles
RAPT Therapeutics currently has no Cashu-related articles
About
What does RAPT do?
Rapt Therapeutics, based in South San Francisco, specializes in developing oral small molecule therapies for oncology and inflammatory diseases, with key candidates targeting CCR4. The company went public on October 31, 2019, and employs 126 people.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.